Drugmakers Eli Lilly, AtaiBeckley saw US merger antitrust wait period expire
MLex Summary: The US premerger antitrust review wait period for the merger of pharmaceutical giant Eli Lilly and psychiatric biotech firm AtaiBeckley expired on Aug. 28, according to a filing with...To view the full article, register now.
Already a subscriber? Click here to view full article